HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Serological cardiolipid development of early syphilis treated with a single injection of benzathine-penicillin of 2,400,000 I.U].

Abstract
For one year, the authors have observed the clinical and biological development of early syphilis on 205 patients infected between 1971 and 1979 and treated by a single injection of Benzathine-Penicilline of 2,400,000 U.I. The serological negativeness has been obtained in the proportions as follow: - 91,43 p. 100 of primary syphilis (blood test positive), - 88,57 p. 100 of secondary syphilis, - 67,69 p. 100 of latent syphilis. These results compared to those obtained by other more time-consuming and expensive methods, can be considered as satisfactory.
AuthorsA Sekkat, M I Ait Bennasser, T S Benhayoune, D Derdabi, O Sedrati, S Nejmi, A Baaj
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 110 Issue 10 Pg. 835-8 ( 1983) ISSN: 0151-9638 [Print] France
Vernacular TitleL'évolution sérologique cardiolipidique de la syphilis précoce traitée par une injection unique de benzathine-pénicilline de 2.400.000 U. I.
PMID6666927 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Penicillin G Benzathine
Topics
  • Humans
  • Injections, Intramuscular
  • Penicillin G Benzathine (administration & dosage)
  • Syphilis (blood, drug therapy)
  • Syphilis Serodiagnosis
  • Syphilis, Latent (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: